Iovance Biotherapeutics (IOVA) Notes Payables (2010 - 2026)
Iovance Biotherapeutics (IOVA) posted quarterly Notes Payables of $1.0 million for Q1 2026, little changed year-over-year from $1.0 million in Q1 2025, and little changed quarter-over-quarter from $1.0 million in Q4 2025.
Iovance Biotherapeutics (IOVA) Notes Payables (2010 - 2026) Analysis & Trends
Iovance Biotherapeutics (IOVA) has reported Notes Payables for 9 consecutive years, with $1.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Notes Payables changed 0.0% year-over-year to $1.0 million; the TTM figure through Mar 2026 stood at $1.0 million (changed 0.0% YoY), while the FY2025 annual figure was $1.0 million, changed N/A from the prior year.
- Notes Payables held at $1.0 million in Q1 2026 per IOVA's latest filing, from $1.0 million in the prior quarter.
- Across five years, Notes Payables topped out at $1.0 million in Q1 2025 and bottomed at $1.0 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Iovance Biotherapeutics | 3.16 Bn | 2.86 Bn | 55.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.00 Mn |
| Dec 31, 2025 | 1.00 Mn |
| Sep 30, 2025 | 1.00 Mn |
| Jun 30, 2025 | 1.00 Mn |
| Mar 31, 2025 | 1.00 Mn |
| Mar 31, 2016 | 86,000.00 |
| Dec 31, 2015 | 86,000.00 |
| Dec 31, 2014 | 86,000.00 |
| Dec 31, 2013 | 338,731.00 |
| Dec 31, 2012 | 5.00 Mn |
| Sep 30, 2012 | 5.00 Mn |
| Jun 30, 2012 | 5.00 Mn |
| Mar 31, 2012 | 17,619.00 |
| Dec 31, 2011 | 5.00 Mn |
| Sep 30, 2011 | 2.60 Mn |
| Jun 30, 2011 | 1.74 Mn |
| Dec 31, 2010 | 792,575.00 |